2025 H1 -tulosraportti
105 päivää sitten48 min
Tarjoustasot
First North Denmark
Määrä
Osto
250 000
Myynti
Määrä
1 665 420
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 37 100 | - | - | ||
| 65 000 | - | - | ||
| 100 000 | - | - | ||
| 39 356 | - | - | ||
| 18 000 | - | - |
Ylin
0,01VWAP
Alin
0,01VaihtoMäärä
0 730 040
VWAP
Ylin
0,01Alin
0,01VaihtoMäärä
0 730 040
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
8 t sitten8 t sitten·2 t sitten · MuokattuWhat is The Longevity Show? The Longevity Show is an international top-conference for: healthy aging prevention digital health evidence-based interventions (for both public healthcare systems, private actors, and policy environments) It is not a care home fair and not a startup pitch scene. It is where: systems thinking clinical evidence scalable health meet. The audience is typically: health system leaders policy advisors researchers major healthcare players investors in infrastructure health (not hype) Why is this big for Ayla? 1️⃣ Ayla is positioned in prevention – not care Devika speaks on the Headline Stage about: > “Cognition & Focus: Training the Brain to Age Better” This means: Ayla is positioned before dementia – not just after diagnosis it moves Ayla into longevity / preventative health budgets a much larger market than “dement care” 2️⃣ Ayla is presented as digital therapy The formulation is important: > “a medical device built on Cognitive Stimulation Therapy” It is: treatment evidence scalable system-ready Not “wellness”. Not “care support”. 👉 Therapeutic intervention. 3️⃣ Global scene = global legitimacy The Longevity environment is: USA UK EU Asia Australia It is the same environment that: influences WHO recommendations shapes national prevention strategies shifts money from hospital → community → digital That Ayla is there = Ayla is seen as a global solution, not a local case. One line that summarizes it all Longevity Show moves Ayla from “dementia software” to “global preventative, prescribable brain health therapy”. It’s a much bigger game.- ·1 päivä sittenTo all b+ interested, just try to keep up out there..
·5 t sittenMingodk, Gold Rush is a fantastic series. And Parker in every way a thoroughly fantastic guy in every way, especially considering how he was taught the old-fashioned way by his grandfather. I wish one could have a debate where both pros and cons can be taken. But alone I am up against a group of naive optimists who totally uncritically hype, worship and greatly praise a management and a company that in every way has been a disaster. They should not be allowed to stand alone with their dishonest and decidedly manipulative hype, so even though I can also spot small good signs occasionally, I focus solely on the critical now that they so unilaterally push their positive lie. And now it's not me who has been wrong about the stock, and no, that's not going to happen, so it shouldn't be me who has to back out. - ·1 päivä sitten · Muokattuhttps://www.linkedin.com/posts/hsj-information-ltd_healthcareinnovation-globalcollaboration-ugcPost-7405274917585252352-gDvC?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4 Fiona Costello (Brain+) is not just “present”, she is in the right room. Here is the tight, fact-based reading of what you have sent: Fiona from Brain+ is appearing on an HSJ-facilitated panel focusing on “Treatment to Prevention”. It is not a random theme, but one of the three absolutely central pillars in the NHS 10-Year Health Plan: moving from hospital-based treatment to prevention in community and social care. The panel is moderated/framed by HSJ Information, which in practice functions as a translator between NHS strategy and the market. This means that the participants are not there for inspiration, but because they represent solutions that already match NHS’ future procurement logic. The fact that Fiona is on the panel together with Homecare Association, The Pioneer Group and system-adjacent profiles, shows that Brain+ is not being positioned as a “tech supplier”, but as a care-model actor. This is precisely the position required to enter the ICS/ICB logic. At the same time, Jyotika Singh (HSJ/NHS-insights) is actively involved both here and in the dialogue with the Danish embassy, Danish industry and ministerial level. This is not export PR – it is policy translation across countries with NHS as the reference architecture. When you connect the dots, the signal is quite clear: Brain+ has not only been accepted as a solution in the NHS context, but is now being used as a concrete case in discussions about scaling, prevention and international knowledge sharing. This significantly reduces the risk of the “pilot trap”. The risk moves away from relevance and into execution and capacity. The fact that Fiona is visible in precisely these forums means that Brain+ is already being read as part of the answer – not as an idea that still needs to be proven.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H1 -tulosraportti
105 päivää sitten48 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 8 t sitten8 t sitten·2 t sitten · MuokattuWhat is The Longevity Show? The Longevity Show is an international top-conference for: healthy aging prevention digital health evidence-based interventions (for both public healthcare systems, private actors, and policy environments) It is not a care home fair and not a startup pitch scene. It is where: systems thinking clinical evidence scalable health meet. The audience is typically: health system leaders policy advisors researchers major healthcare players investors in infrastructure health (not hype) Why is this big for Ayla? 1️⃣ Ayla is positioned in prevention – not care Devika speaks on the Headline Stage about: > “Cognition & Focus: Training the Brain to Age Better” This means: Ayla is positioned before dementia – not just after diagnosis it moves Ayla into longevity / preventative health budgets a much larger market than “dement care” 2️⃣ Ayla is presented as digital therapy The formulation is important: > “a medical device built on Cognitive Stimulation Therapy” It is: treatment evidence scalable system-ready Not “wellness”. Not “care support”. 👉 Therapeutic intervention. 3️⃣ Global scene = global legitimacy The Longevity environment is: USA UK EU Asia Australia It is the same environment that: influences WHO recommendations shapes national prevention strategies shifts money from hospital → community → digital That Ayla is there = Ayla is seen as a global solution, not a local case. One line that summarizes it all Longevity Show moves Ayla from “dementia software” to “global preventative, prescribable brain health therapy”. It’s a much bigger game.
- ·1 päivä sittenTo all b+ interested, just try to keep up out there..·5 t sittenMingodk, Gold Rush is a fantastic series. And Parker in every way a thoroughly fantastic guy in every way, especially considering how he was taught the old-fashioned way by his grandfather. I wish one could have a debate where both pros and cons can be taken. But alone I am up against a group of naive optimists who totally uncritically hype, worship and greatly praise a management and a company that in every way has been a disaster. They should not be allowed to stand alone with their dishonest and decidedly manipulative hype, so even though I can also spot small good signs occasionally, I focus solely on the critical now that they so unilaterally push their positive lie. And now it's not me who has been wrong about the stock, and no, that's not going to happen, so it shouldn't be me who has to back out.
- ·1 päivä sitten · Muokattuhttps://www.linkedin.com/posts/hsj-information-ltd_healthcareinnovation-globalcollaboration-ugcPost-7405274917585252352-gDvC?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4 Fiona Costello (Brain+) is not just “present”, she is in the right room. Here is the tight, fact-based reading of what you have sent: Fiona from Brain+ is appearing on an HSJ-facilitated panel focusing on “Treatment to Prevention”. It is not a random theme, but one of the three absolutely central pillars in the NHS 10-Year Health Plan: moving from hospital-based treatment to prevention in community and social care. The panel is moderated/framed by HSJ Information, which in practice functions as a translator between NHS strategy and the market. This means that the participants are not there for inspiration, but because they represent solutions that already match NHS’ future procurement logic. The fact that Fiona is on the panel together with Homecare Association, The Pioneer Group and system-adjacent profiles, shows that Brain+ is not being positioned as a “tech supplier”, but as a care-model actor. This is precisely the position required to enter the ICS/ICB logic. At the same time, Jyotika Singh (HSJ/NHS-insights) is actively involved both here and in the dialogue with the Danish embassy, Danish industry and ministerial level. This is not export PR – it is policy translation across countries with NHS as the reference architecture. When you connect the dots, the signal is quite clear: Brain+ has not only been accepted as a solution in the NHS context, but is now being used as a concrete case in discussions about scaling, prevention and international knowledge sharing. This significantly reduces the risk of the “pilot trap”. The risk moves away from relevance and into execution and capacity. The fact that Fiona is visible in precisely these forums means that Brain+ is already being read as part of the answer – not as an idea that still needs to be proven.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
250 000
Myynti
Määrä
1 665 420
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 37 100 | - | - | ||
| 65 000 | - | - | ||
| 100 000 | - | - | ||
| 39 356 | - | - | ||
| 18 000 | - | - |
Ylin
0,01VWAP
Alin
0,01VaihtoMäärä
0 730 040
VWAP
Ylin
0,01Alin
0,01VaihtoMäärä
0 730 040
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
2025 H1 -tulosraportti
105 päivää sitten48 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 4.9. | |
| 2024 H2 -tulosraportti | 29.4. | |
| 2024 H1 -tulosraportti | 3.9.2024 | |
| 2023 H2 -tulosraportti | 7.5.2024 | |
| 2023 H1 -tulosraportti | 1.9.2023 |
Datan lähde: Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 8 t sitten8 t sitten·2 t sitten · MuokattuWhat is The Longevity Show? The Longevity Show is an international top-conference for: healthy aging prevention digital health evidence-based interventions (for both public healthcare systems, private actors, and policy environments) It is not a care home fair and not a startup pitch scene. It is where: systems thinking clinical evidence scalable health meet. The audience is typically: health system leaders policy advisors researchers major healthcare players investors in infrastructure health (not hype) Why is this big for Ayla? 1️⃣ Ayla is positioned in prevention – not care Devika speaks on the Headline Stage about: > “Cognition & Focus: Training the Brain to Age Better” This means: Ayla is positioned before dementia – not just after diagnosis it moves Ayla into longevity / preventative health budgets a much larger market than “dement care” 2️⃣ Ayla is presented as digital therapy The formulation is important: > “a medical device built on Cognitive Stimulation Therapy” It is: treatment evidence scalable system-ready Not “wellness”. Not “care support”. 👉 Therapeutic intervention. 3️⃣ Global scene = global legitimacy The Longevity environment is: USA UK EU Asia Australia It is the same environment that: influences WHO recommendations shapes national prevention strategies shifts money from hospital → community → digital That Ayla is there = Ayla is seen as a global solution, not a local case. One line that summarizes it all Longevity Show moves Ayla from “dementia software” to “global preventative, prescribable brain health therapy”. It’s a much bigger game.
- ·1 päivä sittenTo all b+ interested, just try to keep up out there..·5 t sittenMingodk, Gold Rush is a fantastic series. And Parker in every way a thoroughly fantastic guy in every way, especially considering how he was taught the old-fashioned way by his grandfather. I wish one could have a debate where both pros and cons can be taken. But alone I am up against a group of naive optimists who totally uncritically hype, worship and greatly praise a management and a company that in every way has been a disaster. They should not be allowed to stand alone with their dishonest and decidedly manipulative hype, so even though I can also spot small good signs occasionally, I focus solely on the critical now that they so unilaterally push their positive lie. And now it's not me who has been wrong about the stock, and no, that's not going to happen, so it shouldn't be me who has to back out.
- ·1 päivä sitten · Muokattuhttps://www.linkedin.com/posts/hsj-information-ltd_healthcareinnovation-globalcollaboration-ugcPost-7405274917585252352-gDvC?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4 Fiona Costello (Brain+) is not just “present”, she is in the right room. Here is the tight, fact-based reading of what you have sent: Fiona from Brain+ is appearing on an HSJ-facilitated panel focusing on “Treatment to Prevention”. It is not a random theme, but one of the three absolutely central pillars in the NHS 10-Year Health Plan: moving from hospital-based treatment to prevention in community and social care. The panel is moderated/framed by HSJ Information, which in practice functions as a translator between NHS strategy and the market. This means that the participants are not there for inspiration, but because they represent solutions that already match NHS’ future procurement logic. The fact that Fiona is on the panel together with Homecare Association, The Pioneer Group and system-adjacent profiles, shows that Brain+ is not being positioned as a “tech supplier”, but as a care-model actor. This is precisely the position required to enter the ICS/ICB logic. At the same time, Jyotika Singh (HSJ/NHS-insights) is actively involved both here and in the dialogue with the Danish embassy, Danish industry and ministerial level. This is not export PR – it is policy translation across countries with NHS as the reference architecture. When you connect the dots, the signal is quite clear: Brain+ has not only been accepted as a solution in the NHS context, but is now being used as a concrete case in discussions about scaling, prevention and international knowledge sharing. This significantly reduces the risk of the “pilot trap”. The risk moves away from relevance and into execution and capacity. The fact that Fiona is visible in precisely these forums means that Brain+ is already being read as part of the answer – not as an idea that still needs to be proven.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
250 000
Myynti
Määrä
1 665 420
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 37 100 | - | - | ||
| 65 000 | - | - | ||
| 100 000 | - | - | ||
| 39 356 | - | - | ||
| 18 000 | - | - |
Ylin
0,01VWAP
Alin
0,01VaihtoMäärä
0 730 040
VWAP
Ylin
0,01Alin
0,01VaihtoMäärä
0 730 040
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 730 040 | 730 040 | 0 | 0 |